hasTargetDisease
P20980
predicate
Indicates that an entity (such as a treatment, study, or intervention) is directed toward, intended to affect, or primarily concerned with a specified disease.
All labels observed (20)
| Label | Occurrences |
|---|---|
| therapeuticArea | 219 |
| hasTherapeuticArea | 67 |
| targetsDisease | 20 |
| targetDisease | 18 |
| studiesDisease | 8 |
| diseaseArea | 6 |
| therapeuticTargetIn | 5 |
| surveillanceFocusDiseases | 4 |
| diseaseTarget | 3 |
| diseaseTargeted | 2 |
| hasFocusDisease | 2 |
| treatsDiseaseArea | 2 |
| actsOnDisease | 1 |
| combinedWithFlucytosineUsedFor | 1 |
| coveredDisease | 1 |
| diseaseBurdenAddressed | 1 |
| hasFDAIndicationText | 1 |
| hasPrimaryDiseaseFocus | 1 |
| hasTargetDisease canonical | 1 |
| relatedToDisease | 1 |
Description generation (PDg)
The one-sentence description above was generated by prompting gpt-5.1 with the predicate name and this instruction.
Instruction
Given a predicate that represents a relationship or action between entities, generate a one-sentence description explaining its meaning. # Instructions Focus on describing the relationship, not the entities themselves. # Response Format Begin the description with \' Indicates...\'
Input
Predicate: hasTargetDisease
Generated description
Indicates that an entity (such as a treatment, study, or intervention) is directed toward, intended to affect, or primarily concerned with a specified disease.
Sample triples (364)
| Subject | Object |
|---|---|
| Pharmaceuticals Division | ophthalmology via predicate surface "therapeuticArea" ⓘ |
| Pharmaceuticals Division | neuroscience via predicate surface "therapeuticArea" ⓘ |
| Pharmaceuticals Division | cardiovascular and metabolic diseases via predicate surface "therapeuticArea" ⓘ |
| faricimab | ophthalmology via predicate surface "therapeuticArea" ⓘ |
| faricimab | retinal diseases via predicate surface "therapeuticArea" ⓘ |
| aflibercept | ophthalmology via predicate surface "therapeuticArea" ⓘ |
| aflibercept | oncology via predicate surface "therapeuticArea" ⓘ |
| Families First Coronavirus Response Act | COVID-19 via predicate surface "targetsDisease" ⓘ |
| Janssen Biotech | rheumatology via predicate surface "therapeuticArea" ⓘ |
| Janssen Biotech | gastroenterology via predicate surface "therapeuticArea" ⓘ |
| Janssen Biotech | dermatology via predicate surface "therapeuticArea" ⓘ |
| CD38 | multiple myeloma via predicate surface "therapeuticArea" ⓘ |
| CD38 | light chain amyloidosis via predicate surface "therapeuticArea" ⓘ |
| CD38 | chronic lymphocytic leukemia via predicate surface "therapeuticArea" ⓘ |
| CD38 | acute myeloid leukemia via predicate surface "therapeuticArea" ⓘ |
| CD38 | T-cell acute lymphoblastic leukemia via predicate surface "therapeuticArea" ⓘ |
| CD38 |
non-Hodgkin lymphoma
via predicate surface "therapeuticArea"
ⓘ
surface form:
NK/T-cell lymphoma
|
| CD38 | autoimmune diseases via predicate surface "therapeuticArea" ⓘ |
| ENSEMBLE trial |
COVID-19 pandemic
via predicate surface "targetDisease"
ⓘ
surface form:
COVID-19
|
| Ad26.COV2.S |
COVID-19 pandemic
via predicate surface "targetDisease"
ⓘ
surface form:
COVID-19
|
| Established Pharmaceuticals | cardiovascular diseases via predicate surface "therapeuticArea" ⓘ |
| Established Pharmaceuticals | metabolic disorders via predicate surface "therapeuticArea" ⓘ |
| Established Pharmaceuticals | gastrointestinal disorders via predicate surface "therapeuticArea" ⓘ |
| Established Pharmaceuticals | respiratory diseases via predicate surface "therapeuticArea" ⓘ |
| Established Pharmaceuticals | pain management via predicate surface "therapeuticArea" ⓘ |
| Established Pharmaceuticals | women’s health via predicate surface "therapeuticArea" ⓘ |
| Established Pharmaceuticals | central nervous system disorders via predicate surface "therapeuticArea" ⓘ |
| Epidiolex | neurology via predicate surface "therapeuticArea" ⓘ |
| Epidiolex | epileptology via predicate surface "therapeuticArea" ⓘ |
| CD20 protein | B‑cell non‑Hodgkin lymphoma via predicate surface "therapeuticArea" ⓘ |
| CD20 protein | chronic lymphocytic leukemia via predicate surface "therapeuticArea" ⓘ |
| CD20 protein | rheumatoid arthritis via predicate surface "therapeuticArea" ⓘ |
| CD20 protein | multiple sclerosis via predicate surface "therapeuticArea" ⓘ |
| CD20 protein | granulomatosis with polyangiitis via predicate surface "therapeuticArea" ⓘ |
| CD20 protein | microscopic polyangiitis via predicate surface "therapeuticArea" ⓘ |
| CD20 protein | pemphigus vulgaris via predicate surface "therapeuticArea" ⓘ |
| Riabni | oncology via predicate surface "hasTherapeuticArea" ⓘ |
| Riabni | rheumatology via predicate surface "hasTherapeuticArea" ⓘ |
| Riabni | immunology via predicate surface "hasTherapeuticArea" ⓘ |
| CLEOPATRA trial | HER2-positive metastatic breast cancer via predicate surface "targetDisease" ⓘ |
| CLEOPATRA trial | HER2-positive locally recurrent unresectable breast cancer via predicate surface "targetDisease" ⓘ |
| Nicorette | smoking cessation via predicate surface "therapeuticArea" ⓘ |
|
Sinovac
surface form:
CoronaVac
|
COVID-19 pandemic
via predicate surface "targetDisease"
ⓘ
surface form:
COVID-19
|
| Vertex Pharmaceuticals | cystic fibrosis via predicate surface "therapeuticArea" ⓘ |
| Vertex Pharmaceuticals | sickle cell disease via predicate surface "therapeuticArea" ⓘ |
| Vertex Pharmaceuticals | beta thalassemia via predicate surface "therapeuticArea" ⓘ |
| Vertex Pharmaceuticals | pain via predicate surface "therapeuticArea" ⓘ |
| Vertex Pharmaceuticals | type 1 diabetes via predicate surface "therapeuticArea" ⓘ |
| H3 Biomedicine | solid tumors via predicate surface "therapeuticArea" ⓘ |
| H3 Biomedicine | hematologic malignancies via predicate surface "therapeuticArea" ⓘ |